- Home
- Automated
- List of product information
- HYALGAN INJECTION 20 MG/2 ML [SIN06242P]
HYALGAN INJECTION 20 MG/2 ML [SIN06242P]
Active ingredients: HYALGAN INJECTION 20 MG/2 ML
Product Info
HYALGAN INJECTION 20 MG/2 ML
[SIN06242P]
Product information
Active Ingredient and Strength | SODIUM HYALURONATE - 20 MG/2 ML |
Dosage Form | INJECTION |
Manufacturer and Country | FIDIA FARMACEUTICI S.P.A - ITALY |
Registration Number | SIN06242P |
Licence Holder | PHARMAFORTE SINGAPORE PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | S01KA01 |
Therapeutic Indications – Treatment / sustained relief of pain in osteoarthritis of the knee.
Posology and Method of Administration –
Adults (including the elderly) The contents of one vial (20mg/2ml) or prefilled syringe (20mg/2ml) to be injected into the affected joint once a week for a total of five injections, using a standard technique. No adjustment of dose is required in elderly patients. This can be repeated at not less than 6 monthly intervals.
Children – At present there is not enough evidence to recommend a dosage regimen for use in children.
Contra-indications – Hyalectin®, the active principle in Hyalgan®, is of avian origin. Do not administer to patients with known hypersensitivity to any ingredient of the product or to avian proteins.
Intra-articular injections are contra-indicated in cases of infections or skin diseases in the area of the injection site.
